Every month we release new videos for you to learn more about Drug Science. Subscribe to our YouTube Channel for more!

Search Videos

Brain and Mind Made Simple - Prof David Nutt

Get Prof Nutt’s new book in the Drug Science bookstore. This webinar was recorded during a Drug Science Live Event which included a live Q&A session from the audience. If you want to ensure that you don’t miss any of our events, so that you can ask your questions live, all you need to do  …


Can Ayahuasca Treat Depression? - Clinical Insights

What is ayahuasca? Ayahuasca is a psychedelic brew originating from the Amazon, originally used by indigenous populations and later involved for local syncretic purposes. Since it’s origins, ayahuasca has spread across the world and has developed a more varied list of uses. The two hallmark ingredients of ayahuasca are: 1) the leaves of the Psychotria  …


Psychedelics and Diversity - In My Professional Opinion

Increasing Diversity in Psychedelic Science Research In order to generate research that is relevant to the masses, it is imperative that the field of psychedelic science involves a level of diversity that is representative of those it intends to treat. This renaissance of psychedelic research thus far has not sufficiently involved people of colour, in  …


Street Drugs Discussions - Spice

This webinar was recorded during a Drug Science Live Event which included a live Q&A session from the audience. If you want to ensure that you don’t miss any of our events, so that you can ask your questions live, all you need to do is join the Drug Science Mailing List. Drug Science is  …


The Brain, Mind, and Ethics of Psychedelics - Q and A

A fascinating Q&A on the ethical and philosophical considerations in psychedelic science and explanations of the psychedelic experience.   Prof David Nutt David is a leading Neuroscientist and drug policy reform advocate. Formerly the Chief Drug Advisor to the UK government he is currently the Edmond J. Safra Professor of Neuropsychopharmacology and director of the  …


Psychedelic Harm Reduction Workshop - Student Psychedelic Conference

In this webinar from the Student Psychedelic Conference, we hear from two groups doing amazing harm reduction work!   PsyCare Amanda Guzinska started working with PsyCare since 2013 having discovered them at a festival a couple of years prior while helping a friend through a difficult experience. Among her friends or even strangers in need,  …


Effects of Mixing and Dosing MDMA, LSD, and 2C-B with Dr Friederike Meckel Fischer

Dosing in psychoactive drugs Dosing represents one of the three critical elements that determine the quality of a drug experience, alongside set and setting. Determining appropriate dosages can be difficult due to ambiguity in drug purity, drug experience of the individual, tolerance, and the aforementioned set and setting. While these represent general guidelines, experience, variability  …


Working in Drug Science

In this webinar, you will learn about the medicalisation of both psychedelics and cannabis, from two of the biggest experts in these respective fields; Prof Jo Neill, and Prof Mike Barnes. We expect these industries to grow to tremendous size and want to prepare the next generation for a new economy of medicine and psychiatry.  …


Patient Perspective on Psychedelic Therapy - Q and A

A personal Q&A from two patients of psychedelic therapy:   Psilocybin for depression – Michael Bourne Michael Bourne is a 57-year-old website designer from the North East of England, who tried several unsuccessful depression treatments, including talking therapy and prescription medications, before turning to psilocybin clinical trials. Michael took part in research into psilocybin treatment  …


Ayahuasca Research with Dr Simon Ruffell

What Is Ayahuasca? The word ayahuasca is derived from the phrase “vine of the dead”, or “vine of the soul” in Quechuan languages – succinctly capturing its mystical and spiritual role in South American cultures. Ayahuasca is a psychedelic plant brew composed of two primary ingredients: 1) Banisteriopsis caapi and 2) Psychotria viridis. N,N-dimethyltryptamine (DMT),  …


Ask the experts: Psilocybin and MDMA Research

In this webinar, two of the world’s leading psychedelic research experts; Dr Ben Sessa and Dr Meg Spriggs, answer questions on the therapeutic applications of MDMA and psilocybin!   Who is Dr Ben Sessa? Dr Ben Sessa is a consultant child and adolescent psychiatrist who has worked with young people and adults in the field  …


Are Psychedelics Legal in the Netherlands?

Psychedelic drugs in the Netherlands In the Netherlands, it’s not difficult to find a shop selling psychedelic drugs – magic truffles, cacti, 5-Meo-DMT, iboga, and the like are all widely available at ‘smart shops’. Retreat centers are also accessible within the country, where individuals can pay to trip in a safe environment, and undergo therapy  …


The Future of Psychedelics

What does the future of psychedelics look like? In this Drug Science webinar, Sarah Hashkes, breaks down the key factors which will influence the future of psychedelics.   Why do psychedelics have so much potential and what does it have to do with ‘predictive coding’? “Predictive coding” refers to the brain function theory where the  …


Addiction, Trauma and Ayahuasca - The Patient Perspective

In this Drug Science webinar, we learn how ayahuasca may be helpful in the treatment of addiction, trauma, and anger issues from addiction recovery coach Mark Drax, who describes the efficacy of ayahuasca to treat sex addiction. From the age of 3, Mark Drax’ childhood was riddled with physical abuse both in his home and  …


The Future of Festivals

In this webinar, we discuss how festivals can be improved as they return from their 2020 hiatus. Drug use at festivals is unsurprisingly high, and always has been, but organisers are often battling against drug policy in their efforts to improve the safety of festival-goers with harm reduction techniques such as drug testing and psy-care.  …


Legalising Psychedelics

There is no defined road to legalising psychedelics, but there are many options available. Ismail Lourido Ali, of MAPS, discusses the important nuances in this Drug Science webinar on expanding access to psychedelics. Due to the recent progress of medical cannabis legalisation, many expect psychedelics to follow a similar path of medical legalisation, followed by  …


Women in Psychedelic Science - Part 4

This is the full recording of our 4th Women in Psychedelic Science event, hosted in June. Featuring experts working at the cutting edge of psychedelic science and in related fieldwork. Psychedelic medicine: from lab findings to therapeutic applications Dr Kim Kuypers Kim PC Kuypers (PhD) is affiliated as an Associate Professor with Maastricht University, Faculty  …


Psilocybin for OCD (Obsessive Compulsive Disorder)

Could psilocybin be used for the treatment of OCD? Psilocybin is currently being researched as a treatment for OCD by Drug Science founder, Prof David Nutt, at the Centre for Psychedelic Research. In this Drug Science webinar, Dr Nick Sireau provides an overview of OCD and the new research being launched into psilocybin as a  …


Drug Consumption Rooms

Drug Consumption Rooms (DCRs), also known as Supervised/Safe Injection Facilities (SIFs), or Overdose Prevention Centres (OPCs), provide safe environments for people to consume controlled drugs under the supervision of trained professionals who can save lives if medical emergencies such as overdoses take place. These facilities can be a powerful harm reduction strategy when implemented correctly.  …